Montpellier-based startup Womed won grand prize in the i-Lab 2018 competition for its highly innovative medical device: a polymer film that repairs the uterine wall and helps fight against certain types of female infertility
China, the second target marketThe innovation was elaborated by Stéphanie Huberlandt, obstetrician gynecologist at the Nîmes CHU, and Xavier Garric, pharmacist, chemist, and professor at University of Montpellier. Both are co-founders of Womed. In June 2018, the startup won one of the grand prizes in the i-Lab 2018 competition, which recognizes the most remarkable projects.
Founded in 2018, Womed has four employees and is hosted by the University of Montpellier.
The company has plans to develop its activities internationally.
“Montpellier Méditerranée Métropole is very involved in the health sector, and they want to follow young startups like ours. We are considering BIC hosting to join a dynamic and diverse entrepreneur network.”
He plans to release the device on the market within two years, starting in Europe.
“Every year, this innovation could concern five million medical interventions around the world,” adds Gonzague Issenmann.
“China will be our second target market, where this type of infertility is common, notably because the abortion rate is particularly high,” concludes the CEO.